Clinical Trials Browser

Phase 1/2 × Terminated × oregovomab × Clear all

NCT03100006 2022-06-13

ORION-01

Phase 1/2 Terminated

Carcinoma, Ovarian Epithelial

NCT00034138 2007-12-18

A Comparative Pharmacokinetics and Safety Study of OvaRex MAb-B43.13 in Patients With Ovarian Epithelial Carcinoma

Phase 1/2 Terminated

Carcinoma, Ovarian Epithelial, Ovarian Neoplasms